Alcami

Alcami Corporation is a contract development and manufacturing organization (CDMO) based in Wilmington, North Carolina, with over 45 years of experience in the pharmaceutical industry. The company operates globally, with facilities and offices in the US, the Netherlands, and Japan, and focuses on providing end-to-end solutions for small and mid-size pharmaceutical and biotechnology clients. Alcami's key services include active pharmaceutical ingredient (API) development, formulation development, analytical services, packaging and stability studies, and clinical and commercial manufacturing. The company employs around 1,000 personnel, with a significant portion based in Wilmington, and is dedicated to supporting drug development from preclinical stages to commercialization. Recently, Alcami was acquired by private equity firms, highlighting its growth in the pharmaceutical outsourcing sector and its commitment to expanding capabilities in analytical testing and sterile manufacturing.